| Ms Tracie Lynn Tuss, AUD | |
|
143 Bala Ave, Bala Cynwyd, PA 19004-3317 | |
| (610) 747-1100 | |
| (610) 747-1118 |
| Full Name | Ms Tracie Lynn Tuss |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 143 Bala Ave, Bala Cynwyd, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720532476 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | AT006479 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Tracie Lynn Tuss, AUD 143 Bala Ave, Bala Cynwyd, PA 19004-3317 Ph: (610) 747-1100 | Ms Tracie Lynn Tuss, AUD 143 Bala Ave, Bala Cynwyd, PA 19004-3317 Ph: (610) 747-1100 |
News Archive
ViiV Healthcare announced today that the US Food and Drug Administration has approved Triumeq (abacavir 600mg, dolutegravir 50mg and lamivudine 300mg) tablets for the treatment of HIV-1 infection.
Compounds derived from plant-based sources - including garlic, broccoli and medicine plants - confer protective effects against breast cancer, explain researchers at the University of Pittsburgh Cancer Institute (UPCI), partner with the UPMC CancerCenter.
A dynamic slogan designed to grab attention "Be bold. Be daring. Be caring and support decriminalisation," has been used in an attempt by the Royal College of Nursing in the UK, to call on the government to decriminalise prostitution in order to protect the health of vulnerable women and men who feel unable to access NHS and social services.
Smokers in England who want to stop smoking are three times more likely to succeed if they see a trained advisor than if they try by themselves, according to a new study published online today in the medical journal Addiction.
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for KALYDECOTM (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have one of eight additional mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. KALYDECO was first approved in January 2012 for people with CF ages 6 and older who have at least one copy of the G551D mutation.
› Verified 1 days ago
Rise Audiology, Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 143 Bala Ave, Bala Cynwyd, PA 19004 Phone: 610-747-1100 Fax: 610-747-1118 | |
Dr. Victoria Rae Buck, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 143 Bala Ave, Bala Cynwyd, PA 19004 Phone: 610-747-1100 Fax: 610-747-1118 | |
Dr. Tiffany Ashley Connatser, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 143 Bala Ave, Bala Cynwyd, PA 19004 Phone: 610-747-1100 Fax: 610-747-1118 |